This is in comparison to our IL-4 observations, which characterized the early changes in molecular mediators (Figure 4), which would infer that the influenza vaccine triggers IL-4 secretion that facilitates downstream enhanced dendritic cell and Th1-type immune activity, ultimately resulting in attenuated tumor growth. The gene discussed is IL4; the disease is influenza.